Skip to main content

Team

Management Team

Stefan Scherer

Stefan Scherer, MD, PhD

Chief Executive Officer & President

Christopher DeRespino

Christopher J DeRespino

Chief Business Officer

Estelle

Estelle Marrer-Berger, PhD

Chief Development Officer

Marvin Gee

Marvin Gee, PhD

Co-Founder, Vice President, Head of Target Discovery

Susan Wong headshot

Susan Wong, MBA

Vice President, Head of Finance

Antje Walz

Antje Walz, PhD

Vice President, Translational Sciences

Board of Directors

Sean Harper

Sean Harper, MD

Chairman of the Board, Managing Director, Westlake Village BioPartners

Shelley Chu

Shelley Chu, MD, PhD

Partner, Lightspeed Venture Partners

Sean Parker

Sean Parker

Founder and Chairman, Parker Institute for Cancer Immunotherapy (PICI)

John Connolly

John Connolly, PhD

Chief Scientific Officer, Parker Institute for Cancer Immunotherapy (PICI)

David Piacquard

David Piacquad, MBA

Former SVP, Business Development at Amgen

David Allison, PhD

Managing Director, Westlake Village BioPartners (Board Observer)

Stefan Scherer

Stefan Scherer, MD, PhD

Chief Executive Officer & President

John Leonard

John Leonard, M.D.

President and CEO, Intellia Therapeutics

Scientific Advisory Board

Chris Garcia

K. Christopher Garcia, PhD

Co-Founder, Chairman of the Scientific Advisory Board

Lenz Heinz Josef

Heinz-Josef Lenz, MD, PhD, FACP

Associate Director for Clinical Research and Co-Leader of the Translational Science Program at the USC Norris Comprehensive Cancer Center

Mark Davis

Mark Davis, PhD

The Burt and Marion Avery Family Professor, Transplantation and Infection, Microbiology & Immunology (Stanford), HHMI

Stephen Schoenberger

Stephen Schoenberger, PhD

Professor, Developmental Immunology (La Jolla Institute for Immunology)

Christina Curtis

Christina Curtis, PhD, MSc

Endowed Scholar and Associate Professor of Medicine & Genetics (Stanford)

Advisors

Leah Sibener

Leah Sibener, PhD

3T Co-Founder and Scientific Advisor

WE ARE SUPPORTED BY SEVERAL TOP-TIER INVESTORS